Relationship between serum concentrations of persistent organic pollutants and the prevalence of metabolic syndrome among non-diabetic adults: Results from the National Health and Nutrition Examination Survey 1999-2002

Diabetologia

Volumn 50, Issue 9, 2007, Pages 1841-1851

  Lee, D H ^a   Lee, I K ^a   Porta, M ^b   Steffes, M ^c   Jacobs Jr , D R ^d,e  

^a Kyungpook National University School of Medicine   (South Korea)

^b UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

^c UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

^d UNIVERSITY OF MINNESOTA   (United States)

^e UNIVERSITY OF OSLO   (Norway)

Author keywords

Diabetes; Insulin resistance; Metabolic syndrome; Organochlorine pesticides; Persistent organic pollutants; Polychlorinated biphenyls

Indexed keywords

DIOXIN; PESTICIDE; POLYCHLORINATED BIPHENYL; POLYCHLORINATED DIBENZODIOXIN; POLYCHLORINATED DIBENZOFURAN; TRIACYLGLYCEROL;

ADULT; ARTICLE; BLOOD LEVEL; CONTROLLED STUDY; HUMAN; HYPERTENSION; METABOLIC SYNDROME X; ORGANIC POLLUTION; PRIORITY JOURNAL; STATISTICAL SIGNIFICANCE; WAIST CIRCUMFERENCE;

ADULT; CENTERS FOR DISEASE CONTROL AND PREVENTION (U.S.); CROSS-SECTIONAL STUDIES; DIABETES MELLITUS, TYPE 2; ENVIRONMENTAL POLLUTANTS; GAS CHROMATOGRAPHY-MASS SPECTROMETRY; HEALTH SURVEYS; HUMANS; INSULIN RESISTANCE; METABOLIC SYNDROME X; ODDS RATIO; ORGANIC CHEMICALS; PREVALENCE; UNITED STATES;

EID: 34547690603     PISSN: 0012186X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00125-007-0755-4     Document Type: Article

References (40)

1. Wilson PWF, Kannel WB, Silbershatz H, D'Agostino RB (1999) Clustering of metabolic factors and coronary heart disease. Arch Intern Med 159:1104-1109
2. Pladevall M, Singal B, Williams LK et al (2006) A single factor underlies the metabolic syndrome: a confirmatory factor analysis. Diabetes Care 29:113-122
3. Hanson RL, Imperatore G, Bennett PH, Knowler WC (2002) Components of the 'metabolic syndrome' and incidence of type 2 diabetes. Diabetes 51:3120-3127
4. Lakka HM, Laaksonen DE, Lakka TA et al (2002) The metabolic syndrome and total and cardiovascular disease mortality in middle-aged men. JAMA 288:2709-2716
5. Lee DH, Lee IK, Song KE et al (2006) A strong dose-response relation between serum concentrations of persistent organic pollutants and diabetes: results from the National Health and Examination Survey. Diabetes Care 29:1638-1644
6. Lee DH, Lee IK, Jin SH, Steffes M, Jacobs DR Jr (2007) Association between serum concentrations of persistent organic pollutants and insulin resistance among nondiabetic adults: results from the National Health and Nutrition Examination Survey 1999-2002. Diabetes Care 30:622-628
7. Lee DH, Jacobs DR, Porta M (2006) Could low level background exposure to persistent organic pollutants contribute to the social burden of type 2 diabetes? [Editorial]. J Epidemiol Community Health 60:1006-1008
8. Porta M (2006) Persistent organic pollutants and the burden of diabetes. Lancet 368:558-559
9. Fierens S, Mairesse H, Heilier JF et al (2003) Dioxin/polychlorinated biphenyl body burden, diabetes and endometriosis: findings in a population-based study in Belgium. Biomarkers 8:529-534
10. Remillard RB, Bunce NJ (2002) Linking dioxins to diabetes: epidemiology and biologic plausibility. Environ Health Perspect 110:853-858
11. Steenland K, Calvert G, Ketchum N, Michalek J (2001) Dioxin and diabetes mellitus: an analysis of the combined NIOSH and Ranch Hand data. Occup Environ Med 58:641-648
12. Longnecker MP, Klebanoff MA, Brock JW, Zhou H (2001) Collaborative Perinatal Project (CPP). Polychlorinated biphenyl serum levels in pregnant subjects with diabetes. Diabetes Care 24:1099-1101
13. Cranmer M, Louie S, Kennedy RH, Kern PA, Fonseca VA (2000) Exposure to 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) is associated with hyperinsulinemia and insulin resistance. Toxicol Sci 56:431-436
14. NHANES 1999-2000 public data release file documentation [article online] (2005) Available from http://www.cdc.gov/nchs/about/major/nhanes/nhanes99-00. htm, accessed 28 February 2006
15. NHANES 2000-2001 public data release file documentation [article online] (2005) Available from http://www.cdc.gov/nchs/about/major/nhanes/nhanes01-02. htm, accessed 28 February 2006
16. Third national report on human exposure to environmental chemicals (2005) Available from http://www.cdc.gov/exposurereport/3rd/pdf/thirdreport.pdf, accessed 28 February 2006
17. Turner W, DiPietro E, Lapeza C, Green V, Gill J, Patterson DG Jr (1997) A fast universal automated cleanup system for the isotope-dilution HRMS analysis of PCDDs, PCDFs, coplanar PCBs, PCB congeners, and persistent pesticides from the same serum sample. Organohalog Compd 31:26-31
18. Korn EL, Graubard BI (1991) Epidemiologic studies utilizing surveys: accounting for the sampling design. Am J Public Health 81:1166-1173
19. Graubard BI, Korn EL (1999) Analyzing health surveys for cancer-related objectives. J Natl Cancer Inst 91:1005-1016
20. Welshons WV, Thayer KA, Judy BM, Taylor JA, Curran EM, vom Saal FS (2003) Large effects from small exposures. I. Mechanisms for endocrine-disrupting chemicals with estrogenic activity. Environ Health Perspect 111:994-1006
21. Hennig B, Meerarani P, Slim R (2002) Proinflammatory properties of coplanar PCBs: in vitro and in vivo evidence. Toxicol Appl Pharmacol 181:174-183
22. Grundy SM (1999) Hypertriglyceridemia, insulin resistance, and the metabolic syndrome. Am J Cardiol 83:25F-29F
23. Lillioja S, Mott DM, Spraul M et al (1993) Insulin resistance and insulin secretory dysfunction as precursors of non-insulin-dependent diabetes mellitus: prospective studies of Pima Indians. N Engl J Med 329:1988-1992
24. Warram JH, Martin BC, Krolewski AS, Soeldner JS, Kahn CR (1990) Slow glucose removal rate and hyperinsulinemia precede the development of type II diabetes in the offspring of diabetic parents. Ann Intern Med 113:909-915
25. Cheal KL, Abbasi F, Lamendola C, McLaughlin T, Reaven GM, Ford ES (2004) Relationship to insulin resistance of the adult treatment panel III diagnostic criteria for identification of the metabolic syndrome. Diabetes 53:1195-1200
26. Liao Y, Kwon S, Shaughnessy S et al (2004) Critical evaluation of adult treatment panel III criteria in identifying insulin resistance with dyslipidemia. Diabetes Care 27:978-983
27. McLaughlin T, Abbasi F, Cheal K, Chu J, Lamendola C, Reaven G (2003) Use of metabolic markers to identify overweight individuals who are insulin resistant. Ann Intern Med 139:802-809
28. Meigs JB (2000) Invited commentary: insulin resistance syndrome? Syndrome X? Multiple metabolic syndrome? A syndrome at all? Factor analysis reveals patterns in the fabric of correlated metabolic risk factors. Am J Epidemiol 152:908-911
29. Needham LL, Barr DB, Caudill SP et al (2005) Concentrations of environmental chemicals associated with neurodevelopmental effects in U.S. population. Neurotoxicology 26:531-545
30. Fujiyoshi PT, Michalek JE, Matsumura F (2006) Molecular epidemiologic evidence for diabetogenic effects of dioxin exposure in U.S. Air force veterans of the Vietnam war. Environ Health Perspect 114:1677-1683
31. Luross JM, Alaee M, Sergeant DB et al (2002) Spatial distribution of polybrominated diphenyl ethers and polybrominated biphenyls in lake trout from the Laurentian Great Lakes. Chemosphere 46:665-672
32. Anway MD, Cupp AS, Uzumcu M, Skinner MK (2005) Epigenetic transgenerational actions of endocrine disruptors and male fertility. Science 308:1466-1469
33. Titus-Ernstoff L, Troisi R, Hatch EE et al (2006) Menstrual and reproductive characteristics of women whose mothers were exposed in utero to diethylstilbestrol (DES). Int J Epidemiol 35:862-868
34. Thornton J (2000) Beyond risk: an ecological paradigm to prevent global chemical pollution. Int J Occup Environ Health 6:318-330
35. Gallou-Kabani C, Junien C (2005) Nutritional epigenomics of metabolic syndrome: new perspective against the epidemic. Diabetes 54:1899-1906
36. Hansen JC (2000) Environmental contaminants and human health in the Arctic. Toxicol Lett 112-113:119-125
37. Jorgensen ME, Bjeregaard P, Borch-Johnsen K (2002) Diabetes and impaired glucose tolerance among the Inuit population of Greenland. Diabetes Care 25:1766-1771
38. Jorgensen ME, Bjerregaard P, Gyntelberg F, Borch-Johnsen K, Greenland Population Study (2004) Prevalence of the metabolic syndrome among the Inuit in Greenland. A comparison between two proposed definitions. Diabet Med 21:1237-1242
39. Yoon KH, Lee JH, Kim JW et al (2006) Epidemic obesity and type 2 diabetes in Asia. Lancet 368:1681-1688
40. Greenpeace (2000) Unseen poisons in Asia. Available from http://www.greenpeace.to/publications_pdf/asiapops.pdf, accessed 20 February 20 2007